Florida MD published an article written by Christopher Ramsey, Ph.D. in its September issue covering medical technology patents affected by the U.S. Supreme Court.
Several recent decisions by the U.S. Supreme Court affect the extent to which two important classes of medical technology inventions are patentable: those inventions that involve (1) natural products or (2) natural processes. By themselves, natural products and processes have never qualified as patentable subject matter, while isolated natural products and practical applications of natural process have been patentable. Many patented blockbuster drugs and medical treatment methods are derived from natural products or the body's natural processes.
To continue reading the article, click here. To learn more about Florida MD, please visit its website.
If you have any questions concerning this topic, please contact the member of our GrayRobinson health care practice group member with whom you work.
Christopher M. Ramsey, Ph.D.
GrayRobinson, P.A.
301 East Pine Street
Suite 1400
Orlando, FL 32801
Phone: 407.843.8880
Fax: 407.244.5690
Health Law E-lert -- Medical Technology Patents Affected by U.S. Supreme Court
This content is for the general education of our readers, and should not be your sole source of information in handling a legal issue, nor should you substitute it for legal advice, which relies on specific factual analysis and the laws of the relevant jurisdictions. This content is not intended to create, nor does its receipt constitute, an attorney-client relationship. If you have specific questions, consult your GrayRobinson representative or other competent legal counsel.